A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT06046729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to find the appropriately safe and effective dose and dosing frequency for eltrekibart in adults with moderate-to-severe hidradenitis suppurativa (HS) for further clinical development. The study will last approximately 62 weeks and may include up to 31 visits.
Study identification
- NCT ID
- NCT06046729
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 352 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2023 (Actual)
- Primary completion
- Sep 30, 2025 (Actual)
- Completion
- Aug 17, 2026 (Actual)
- Last update posted
- Aug 21, 2026
2023 – 2026
United States locations
- U.S. sites
- 42
- U.S. states
- 24
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists | Phoenix | Arizona | 85006 | — |
| Saguaro Dermatology Associates, LLC - Probity - PPDS | Phoenix | Arizona | 85008 | — |
| Arkansas Research Trials, LLC | North Little Rock | Arkansas | 72117 | — |
| Northwest Arkansas Clinical Trials Center | Rogers | Arkansas | 72758 | — |
| First OC Dermatology Research Inc | Fountain Valley | California | 92708 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Dermatology Institute and Skin Care Center | Santa Monica | California | 90404 | — |
| University of Connecticut | Farmington | Connecticut | 06032 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| University of Miami | Miami | Florida | 33125 | — |
| Skin Research of South Florida | Miami | Florida | 33173-1407 | — |
| ForCare Clinical Research | Tampa | Florida | 33613-1244 | — |
| Alliance Clinical Research of Tampa | Tampa | Florida | 33615 | — |
| Olympian Clinical Research | Tampa | Florida | 33615 | — |
| Advanced Medical Research, PC | Sandy Springs | Georgia | 30328 | — |
| NorthShore Medical Group Dermatology - Skokie | Skokie | Illinois | 60077-1049 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | — |
| Equity Medical - Bowling Green | Bowling Green | Kentucky | 42104 | — |
| Derm Research LLC | Louisville | Kentucky | 40217 | — |
| Care Access-Marriottsville | Marriottsville | Maryland | 21104 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Revival Research Institute - Troy | Troy | Michigan | 48084 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Skin Specialists, P.C | Omaha | Nebraska | 68144 | — |
| ActivMed Practices & Research, Inc. | Portsmouth | New Hampshire | 03801 | — |
| Darst Dermatology | Charlotte | North Carolina | 28277-8014 | — |
| Dermatology Specialists of Charlotte | Charlotte | North Carolina | 28277 | — |
| Duke University Medical Center | Durham | North Carolina | 27710-3038 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Apex Clinical Research Center | Mayfield Heights | Ohio | 44124 | — |
| DermDox Centers for Dermatology | Camp Hill | Pennsylvania | 17011 | — |
| DermDox Dermatology Centers | Sugarloaf | Pennsylvania | 18249 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Columbia Dermatology & Aesthetics | Columbia | South Carolina | 29212-8623 | — |
| International Clinical Research - Tennessee (IC Research) | Murfreesboro | Tennessee | 37130 | — |
| Advanced Research Experts | Nashville | Tennessee | 37211 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| North Texas Clinical Research | Frisco | Texas | 75034 | — |
| Jordan Valley Dermatology Center | South Jordan | Utah | 84095 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202-1332 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06046729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06046729 live on ClinicalTrials.gov.